In two recent studies by Altman et al. and ourselves it was demonstrated that MYC has the potential to dampen the circadian clock by repressing the core transcription activator gene BMAL1 (refs 1, 2). Although the main finding was reported in both studies, different mechanisms have been proposed for the MYC-dependent downregulation of the core clock genes. Altman et al. suggested that MYC induces REV-ERBα, which disrupts the clock by repressing BMAL1. We found that MYC disrupts the clock in U2OS cells through a complex with MIZ1 that directly binds to and represses BMAL1 and CLOCK. Data presented here and in the accompanying correspondence strongly suggest that MYC can impact on the circadian clock through both limbs, direct repression via MIZ1 and indirect repression via induction of REV-ERBα.
Dependent on partner proteins, MYC can act as a transcription activator and repressor of a large number of genes3. MYC in a complex with MAX is a bHLH transcription activator that binds to E-boxes, and MYC/MAX in a complex with the transcription activator MIZ1 constitute a repressor of MIZ1 regulated genes. This repressive complex promotes cell cycle progression and growth by repressing the cyclin-dependent kinase inhibitors genes p15 and p21 (ref. 3).
The heterodimeric bHLH transcription factor BMAL1/CLOCK is a core element of the circadian clock, which activates expression of the negative regulators PERs, CRYs and REV-ERBα/β. PER and CRY proteins inactivate BMAL1/CLOCK while REV-ERBs are repressors of ROR-mediated transcription of BMAL1 and CLOCK genes. ChIP-seq analyses indicate that MYC binds to E-boxes in PER, CRY and REV-ERB genes and also to MIZ1 sites in the promoters of BMAL1 and CLOCK (refs 1, 2).
Altman et al. reported that overexpression of MYC in U2OS cells and MYCN in neuroblastoma-derived cells correlates with increased expression of REV-ERBα, and they proposed that MYC activates REV-ERBα, which then represses BMAL1. Based on the well-established wiring of the transcriptional network of the circadian clock there is no doubt that accumulation of sufficient amounts of REV-ERBα will repress BMAL1, and it has been shown experimentally that overexpressed REV-ERBα disrupts the circadian clock in mouse liver4.
We had shown that overexpression of MYC mutant versions that were compromised in their capacity to interact with MIZ1 but were functional as E-box-dependent activators did not substantially affect circadian oscillations in U2OS cells. This suggests a mode of MYC action different from the induction of REV-ERBα. In addition, knockdown of MIZ1 by siRNA rescued most of the MYC-induced downregulation of the circadian clock, demonstrating that MYC acts via MIZ1. Since we did not see MYC-dependent upregulation of REV-ERBα in U2OS cells, we concluded that MIZ1-mediated repression is the major pathway by which overexpressed MYC mutes the circadian clock in U2OS cells.
Discrepancies in the interpretation of very similar observations between Altman et al. and our paper are based on apparent differences in MYC-induced levels of REV-ERBα in U2OS cells. Altman et al. reported that U2OS cells overexpressing MYC displayed elevated expression of REV-ERBα (∼2-fold), a finding that was not observed in our study1,2. In contrast, induction of MYCN in neuroblastoma-derived cells was accompanied by a much more substantial accumulation of REV-ERBα.
We realized that we and Altman et al. used different amplicons to assess expression, and that data were normalized to different housekeepers, GAPDH and B2M, respectively. Hence, using our published samples, we reanalysed mRNA expression levels with primers used by us (same primers as Zhang et al.5) and by Altman et al. REV-ERBα amplicons used in both studies showed identical behaviour and when normalized to GAPDH, confirmed that REV-ERBα levels were slightly reduced in U2OS cells overexpression MYC (Fig. 1a). However, relative to B2M, REV-ERBα levels (assessed with both amplicons) were slightly elevated at 24 h and essentially unaffected at 36 h.
We confirmed this difference in normalization with independent cDNA profiles from U2OS cells overexpressing MYC (Fig. 1b). Quantification of samples using TaqMan instead of SYBR green yielded similar results (Supplementary Fig. 1a). The data demonstrate that the different reference genes (GAPDH versus B2M) used in both studies are responsible for the discrepancy in quantification of MYC-dependent expression of REV-ERBα. Considering that MYC is a global transcription regulator it is quite challenging to identify ideal housekeepers. Thus, due to the lack of a suitable reference it is difficult to assess small differences in mRNA levels triggered by overexpressed MYC in U2OS cells.
However, ultimately REV-ERBα protein rather than RNA will impact on the circadian clock. Therefore, we as well as Altman et al. (see correspondence) analysed REV-ERBα protein. We tested two independent U2OS clones (#C8 and #10) harbouring inducible MYC. In clone #C8, which was used in our published study, REV-ERBα protein levels decreased upon MYC induction, whereas in clone #10 the levels increased slightly (Supplementary Fig. 1b). A more detailed circadian profile of clone #10 revealed that expression levels of REV-ERBα were generally slightly higher when MYC was induced, with the exception of the 48 h timepoint, which corresponds to the circadian peak of REV-ERBα (Fig. 1c). In average, REV-ERBα levels were about 1.2-fold higher in U2OS cells overexpressing MYC (Fig. 2a). This raises the question whether this moderate increase in REV-ERBα levels is sufficient to account for the MYC-induced disruption of the circadian clock.
Interestingly, MYC-dependent downregulation of BMAL1 and CLOCK was observed in both cell lines (clones #C8 and #10) independent of whether REV-ERBα levels were slightly reduced (#C8) or elevated (#10). This suggests that the downregulation of BMAL1 and CLOCK did not correlate with REV-ERBα levels.
We then analysed the relative repressive potential of MYC-induced REV-ERBα in comparison to the MYC/MIZ1-mediated direct repression of BMAL1 and CLOCK. When REV-ERBα was downregulated with specific siRNA1, REV-ERBα protein was efficiently depleted (Fig. 2a). As expected, absence of REV-ERBα was accompanied by elevated expression of BMAL1 and CLOCK, demonstrating the repressive capacity of REV-ERBα in U2OS cells. However, induction MYC resulted in a two- to threefold reduction of BMAL1 and CLOCK protein levels in absence and presence of REV-ERBα (Fig. 2a), indicating that MYC can repress BMAL1 and CLOCK by a pathway independent of REV-ERBα.
REV-ERBs and RORs regulate expression of BMAL1 via ROR elements (ROREs). Mutation of both ROREs in a Bmal1-luc reporter disrupts its activation by RORs and its inhibition by REV-ERBs, and thus leads to an arrhythmic luciferase expression profile6,7. To assess whether downregulation of Bmal1-luc by overexpressed MYC is dependent on intact ROREs we constructed a Bmal1-luc reporter lacking both ROREs (Bmal1-ΔRORE1,2-luc). U2OS cells transfected with Bmal1-ΔRORE1,2-luc expressed luciferase in arrhythmic fashion (Fig. 2b). However, Bmal1-ΔRORE1,2-luc was still repressed upon induction of MYC indicating a REV-ERB-independent mechanism of inhibition. Nonetheless, the MYC-induced repression of Bmal1-ΔRORE1,2-luc was slightly weaker as compared to the wild-type Bmal1-luc reporter (60% versus 80% of repression at the first peak, respectively) suggesting that REV-ERBs contribute to the repression in addition to MYC/MIZ1. Hence, direct repression of BMAL1 and CLOCK by MYC/MIZ1 appears to be the dominant pathway by which MYC disrupts the circadian clock in U2OS cells.
However, in comparison to the U2OS system, Altman et al. observed a much stronger upregulation of REV-ERBα induced by MYCN in neuroblastoma-derived cell lines (accompanying correspondence). Under these conditions REV-ERBα is likely to be the dominant repressor disrupting the circadian clock.
Taken together, both papers and this correspondence show that MYC can in principle impinge via two pathways on the circadian clock (Fig. 2c). On one hand, MYC is an E-box-dependent activator with the potential to indirectly affect the clock by inducing REV-ERBα/β, which are repressors of BMAL1 and CLOCK. On the other hand, MYC, in a complex with MIZ1, is a direct repressor of BMAL1 and CLOCK. Whether these pathways are effective and which of both pathways is prevalent may depend on the cell type and conditions. It is tempting to speculate that the MIZ1- and REV-ERB-dependent pathways could be regulated independently and thus cooperatively modulate circadian gene expression according to different developmental states, growth conditions and metabolic cues.
Cell culture and transfections
U2OS t-rex tetO-MYC cells1 were maintained in DMEM supplemented with 10% FBS, 1x PenStrep, 50 μg ml−1 hygromycin, and 50 μg ml−1 zeocin (InvivoGen). All reagents for the cell culture were purchased from Life Technologies unless indicated differently. Twenty-four hours before synchronization, U2OS cells were transfected with siRNAs1 using lipofectamine RNAiMAX reagent according to the manufacturer’s protocol. For luciferase recordings, U2OS cells were transfected with reporter constructs using Xfect (Clontech) and next day, cells were synchronized with 1 μM dexamethasone for 20 min and washed with PBS. After addition of warm luminescene medium (DMEM w/o Phenolred supplemented with 10% FBS, 25 mM Hepes, 1x PenStrep, and 0.125 μM luciferin (BioSynth), 10 ng ml−1 doxycycline) the plate was sealed and bioluminescence was recorded at 37 °C with an EnSpire Reader (Perkin Elmer).
Gene expression analysis
Total RNA was isolated using TriFaster (GeneON) and cDNA was synthesized with Maxima First Strand cDNA Synthesis Kit (Thermo Scientific). qPCR was performed using Green-Dye-Mastermix (Steinbrenner), TaqMan Gene Expression Master Mix (Applied Biosystems) and LightCycler 480 (Roche), and relative gene expression was quantified using a ΔΔCt method with respective reference gene (GAPDH or B2M). SYBR green primers were published previously2,5. TaqMan primer sequences are listed in Supplementary Table 1.
Protein lysates were prepared from synchronized U2OS t-rex tetO-MYC cells and blotted on nitrocellulose membranes. Membranes were incubated in 5% milk TBS at 4 °C overnight supplemented with anti-BMAL1 (ref. 1) (1:750), anti-CLOCK (ref. 1) (1:500), anti-Tubulin (1:1,000, WA3), anti-MYC (1:400, N-262, SantaCruz) and anti-REV-ERBα (1:1,000, 13418S, Cell Signaling) antibodies. Proteins were quantified using ImageJ by normalizing to Tubulin. Uncropped blots are shown in Supplementary Fig. 2.
The data supporting the findings of this study are available within the article and its Supplementary Information files, or from the authors on request.
How to cite this article: Shostak, A. et al. Correspondence: Reply to ‘Oncogenic MYC persistently upregulates the molecular clock component REV-ERBα’. Nat. Commun. 8, 14918 doi: 10.1038/ncomms14918 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Shostak, A. et al. MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation. Nat. Commun. 7, 11807 (2016).
Altman, B. J. et al. MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metab. 22, 1009–1019 (2015).
Kress, T. R., Sabo, A. & Amati, B. MYC: connecting selective transcriptional control to global RNA production. Nat. Rev. Cancer 15, 593–607 (2015).
Kornmann, B., Schaad, O., Bujard, H., Takahashi, J. S. & Schibler, U. System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol. 5, e34 (2007).
Zhang, E. E. et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 139, 199–210 (2009).
Hirota, T. et al. Transcriptional repressor TIEG1 regulates Bmal1 gene through GC box and controls circadian clockwork. Genes Cells 15, 111–121 (2010).
Liu, A. C. et al. Redundant function of REV-ERBalpha and beta and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 4, e1000023 (2008).
The work was supported by funds of the Deutsche Forschungsgemeinschaft (SFB 1036). M.B. is a member of CellNetworks.
The authors declare no competing financial interests.
About this article
Trends in Endocrinology & Metabolism (2019)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018)
Annual Review of Cancer Biology (2018)